Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06527482
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-25
Brief Title:
Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Prospective Cohort Study of Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to establish a multicenter prospective cohort of patients with severe osteochondral lesion of the talus OLT evaluate the clinical efficacy of autologous osteoperiosteal transplantation and the incidence of postoperative donor-site morbidity The main questions it aims to answer are
Does autologous osteoperiosteal transplantation have good clinical outcomes in the treatment of severe OLT Does autologous osteoperiosteal transplantation treat severe OLT with fewer postoperative complications
Participants will
Undergo autologous osteoperiosteal transplantation for OLT Receive clinical follow-up 3 6 12 and 24 months after surgery and answer scales of ankle function assessment Take CT and MRI preoperatively and 12 and 24 months after surgery
Does autologous osteoperiosteal transplantation have good clinical outcomes in the treatment of severe OLT Does autologous osteoperiosteal transplantation treat severe OLT with fewer postoperative complications
Participants will
Undergo autologous osteoperiosteal transplantation for OLT Receive clinical follow-up 3 6 12 and 24 months after surgery and answer scales of ankle function assessment Take CT and MRI preoperatively and 12 and 24 months after surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None